BioVersys brings Sfr80m Swiss IPO for new antibiotics

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Equity

BioVersys brings Sfr80m Swiss IPO for new antibiotics

Arthur Bautzer
January 21, 2025 05:42 PM
Decision follows successful Phase 2 trial on ICU patients last year

Decision follows successful Phase 2 trial on intensive care patients

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

EquityEquity IPOsHealth and Biotech
AB
Arthur Bautzer
Gift this article